Schubert & CO Myriad Genetics Inc Transaction History

Schubert & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	BUY	$15.26 - $23.75 $152 - $237	10 Added 34.48%	39 $0
Q4 2022 Jan 31, 2023	SELL	$14.51 - $20.99 $43 - $62	-3 Reduced 9.38%	29 $0
Q3 2022 Oct 21, 2022	BUY	$18.21 - $27.88 $54 - $83	3 Added 10.34%	32 $1,000
Q2 2022 Aug 01, 2022	BUY	$16.45 - $25.88 $312 - $491	19 Added 190.0%	29 $1,000
Q1 2022 May 16, 2022	BUY	$22.67 - $28.01 $113 - $140	5 Added 100.0%	10 $0
Q4 2021 Jan 28, 2022	BUY	$24.13 - $32.63 $120 - $163	5 New	5 $0

254

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.3B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

Stay updated on Schubert & CO with notifications on news.